Verona Pharma plc Verona Pharma Plc: Pdmr Dealings
July 17 2020 - 12:47PM
UK Regulatory
TIDMVRP
LONDON, United Kingdom and RALEIGH, N.C., July 17, 2020 (GLOBE NEWSWIRE)
-- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) ("Verona Pharma" or the
"Company"), a clinical-stage biopharmaceutical company focused on
respiratory diseases, provides further details regarding the
transactions by persons discharging managerial responsibilities
("PDMRs") in connection with the $200 million Financing announced
earlier today.
Capitalised terms in this announcement have the same meanings to those
defined in the Financing announcement which was released at 7.00 a.m. on
July 17, 2020, unless otherwise indicated.
PDMR Purchases
Verona Pharma notifies the following transactions by PDMRs in its
Ordinary Shares or ADSs through participation in the Financing.
No. of Total number of
Ordinary No. of Ordinary Shares Interest in
Shares to ADSs to or ADSs held Company
PDMR be be Total following following
Name purchased purchased consideration Closing Closing
617,603
David (ordinary
Ebsworth 222,216 - GBP99,659.71 shares) 0.13%
David 77,829
Zaccardelli - 55,555 $249,997.50 (ADSs) 0.13%
Anders 33,333
Ullman - 33,333 $149,998.50 (ADSs) 0.06%
Martin 6,666
Edwards - 6,666 $29,997 (ADSs) 0.01%
Mark 33,360
Hahn - 22,223 $100,003.50 (ADSs) 0.06%
The Company notes that participation of Mr Vikas Sinha as disclosed in
the Financing announcement is not required to be notified as a PDMR
dealing as the subscription was not made by Mr Sinha, nor any persons
closely associated with him (in accordance with the definitions under
MAR) but was made by the trustees of certain family members of Mr Sinha.
For further information, please contact:
Verona Pharma plc Tel: +44 (0)20 3283 4200
David Zaccardelli, Chief Executive Officer info@veronapharma.com
Victoria Stewart, Director of Communications
N+1 Singer (Nominated Adviser and UK Broker) Tel: +44 (0)20 7496 3000
Aubrey Powell / George Tzimas / Iqra Amin (Corporate
Finance)
Tom Salvesen (Corporate Broking)
1 Details of the person discharging managerial responsibilities
/ person closely associated
------------------------------------------------------------------------------------------
a) Name Dr David Ebsworth
----------------------------------------------------------- -----------------------------
2 Reason for the notification
------------------------------------------------------------------------------------------
a) Position/status Non-Executive Chairman
----------------------------------------------------------- -----------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- -----------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- -----------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- -----------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary Shares
Identification code ISIN Code: GB00BYW2KH80
----------------------------------------------------------- -----------------------------
b) Nature of the transaction Purchase of Ordinary Shares
----------------------------------------------------------- -----------------------------
c) Price(s) and volume(s)
Price(s) Volume(s)
----------- ------------
GBP0.45 222,216
Ordinary
Shares
----------------------------------------------------------- ----------- ------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- -----------------------------
e) Date of the transaction 14 July 2020
----------------------------------------------------------- -----------------------------
f) Place of the transaction London Stock Exchange, AIM
----------------------------------------------------------- -----------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
-------------------------------------------------------------------------------------------------------------------------
a) Name Dr David Zaccardelli
----------------------------------------------------------- ------------------------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------------------------------------------------------
a) Position/status Chief Executive Officer
----------------------------------------------------------- ------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- ------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- ------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- ------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
-------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument American Depositary Shares ("ADSs"), each representing
8 Ordinary Shares.
Identification code ISIN Code: US9250501064
----------------------------------------------------------- ------------------------------------------------------------
b) Nature of the transaction Subscription to purchase ADSs
----------------------------------------------------------- ------------------------------------------------------------
c) Price(s) and volume(s)
Price(s) Volume(s)
-------------------------- ----------------------------
$4.50 55,555 ADSs
----------------------------------------------------------- -------------------------- ----------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- ------------------------------------------------------------
e) Date of the transaction 14 July 2020
----------------------------------------------------------- ------------------------------------------------------------
f) Place of the transaction NASDAQ
----------------------------------------------------------- ------------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
-------------------------------------------------------------------------------------------------------------------------
a) Name Dr Anders Ullman
----------------------------------------------------------- ------------------------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
----------------------------------------------------------- ------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- ------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- ------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- ------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
-------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument American Depositary Shares ("ADSs"), each representing
8 Ordinary Shares.
Identification code ISIN Code: US9250501064
----------------------------------------------------------- ------------------------------------------------------------
b) Nature of the transaction Subscription to purchase ADSs
----------------------------------------------------------- ------------------------------------------------------------
c) Price(s) and volume(s)
Price(s) Volume(s)
-------------------------- ----------------------------
$4.50 33,333 ADSs
----------------------------------------------------------- -------------------------- ----------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- ------------------------------------------------------------
e) Date of the transaction 14 July 2020
----------------------------------------------------------- ------------------------------------------------------------
f) Place of the transaction NASDAQ
----------------------------------------------------------- ------------------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
-------------------------------------------------------------------------------------------------------------------------
a) Name Dr Martin Edwards
----------------------------------------------------------- ------------------------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
----------------------------------------------------------- ------------------------------------------------------------
b) Initial notification /Amendment Initial Notification
----------------------------------------------------------- ------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
----------------------------------------------------------- ------------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
----------------------------------------------------------- ------------------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
-------------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument American Depositary Shares ("ADSs"), each representing
8 Ordinary Shares.
Identification code ISIN Code: US9250501064
----------------------------------------------------------- ------------------------------------------------------------
b) Nature of the transaction Subscription to purchase ADSs
----------------------------------------------------------- ------------------------------------------------------------
c) Price(s) and volume(s)
Price(s) Volume(s)
-------------------------- ----------------------------
$4.50 6,666 ADSs
----------------------------------------------------------- -------------------------- ----------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
----------------------------------------------------------- ------------------------------------------------------------
e) Date of the transaction 14 July 2020
----------------------------------------------------------- ------------------------------------------------------------
f) Place of the transaction NASDAQ
----------------------------------------------------------- ------------------------------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
--- --------------------------------------------------------------------------------------------------------------------
a) Name Mark Hahn
--- ------------------------------------------------------------ ------------------------------------------------------
2 Reason for the notification
--- --------------------------------------------------------------------------------------------------------------------
a) Position/status Chief Financial Officer
--- ------------------------------------------------------------ ------------------------------------------------------
b) Initial notification /Amendment Initial Notification
--- ------------------------------------------------------------ ------------------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
--- --------------------------------------------------------------------------------------------------------------------
a) Name Verona Pharma plc
--- ------------------------------------------------------------ ------------------------------------------------------
b) Legal Entity Identifier 213800EVI6O6J3TIAL06
--- ------------------------------------------------------------ ------------------------------------------------------
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
4 where transactions have been conducted
--- --------------------------------------------------------------------------------------------------------------------
American Depositary Shares ("ADSs"), representing
a) Description of the financial instrument, type of instrument 8 Ordinary Shares.
Identification code ISIN Code: US9250501064
--- ------------------------------------------------------------ ------------------------------------------------------
b) Nature of the transaction Subscription to purchase ADSs
--- ------------------------------------------------------------ ------------------------------------------------------
c) Price(s) and volume(s)
Price(s) Volume(s)
------------------------ -------------------------
$4.50 22,223
---------------------------------------------------------------- ------------------------ -------------------------
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
--- ------------------------------------------------------------ ------------------------------------------------------
e) Date of the transaction 14 July 2020
--- ------------------------------------------------------------ ------------------------------------------------------
f) Place of the transaction NASDAQ
--- ------------------------------------------------------------ ------------------------------------------------------
(END) Dow Jones Newswires
July 17, 2020 12:47 ET (16:47 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jul 2023 to Jul 2024
